Cargando…

Diminished production of type-I interferons and interleukin-2 in patients with multiple sclerosis

Several lines of evidence have supported the role of immunological mechanisms in the pathogenesis of multiple sclerosis (MS) and new immunomodulatory strategies for its treatment, e.g. subcutaneous application of interferon (IFN)-β, have emerged. We investigated the ability of peripheral blood monon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wandinger, Klaus-Peter, Wessel, Karl, Neustock, Petra, Siekhaus, Aja, Kirchner, Holger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science B.V. 1997
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127026/ https://www.ncbi.nlm.nih.gov/pubmed/9168171 http://dx.doi.org/10.1016/S0022-510X(97)05383-5

Ejemplares similares

Impact of Diminished Expression of circRNA on Multiple Sclerosis Pathomechanisms
por: Mycko, Marcin P., et al.
Publicado: (2022)

The Effect of Levothyroxine on Serum Levels of Interleukin 10 and Interferon-gamma in Rat Model of Multiple Sclerosis
por: Payghani, Cobra, et al.
Publicado: (2017)

Interferons and Natalizumab for Multiple Sclerosis
por: Clar, Christine, et al.
Publicado: (2008)

Beta-interferons in multiple sclerosis
por: Aggarwal, Sourabh, et al.
Publicado: (2010)

Interferon Treatment of Multiple Sclerosis
por: Alajbegovic, Azra, et al.
Publicado: (2012)

Endogenous and Recombinant Type I Interferons and Disease Activity in Multiple Sclerosis
por: Sellebjerg, Finn, et al.
Publicado: (2012)

Gallic acid diminishes pro-inflammatory interferon-γ- and interleukin-17-producing sub-populations in vitro in patients with psoriasis
por: Tsiogkas, Sotirios G., et al.
Publicado: (2023)

Multiple sclerosis–like lesions and type I interferon signature in a patient with RVCL
por: Schuh, Elisabeth, et al.
Publicado: (2014)

Cellular senescence in progenitor cells contributes to diminished remyelination potential in progressive multiple sclerosis
por: Nicaise, Alexandra M., et al.
Publicado: (2019)

Exercise Diminishes Plasma Neurofilament Light Chain and Reroutes the Kynurenine Pathway in Multiple Sclerosis
por: Joisten, Niklas, et al.
Publicado: (2021)

Interferon gamma inhibits interleukin 10 production by monocytes
Publicado: (1993)

Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance
por: Hundeshagen, Alexander, et al.
Publicado: (2012)

AhR diminishes the efficacy of chemotherapy via suppressing STING dependent type-I interferon in bladder cancer
por: Ma, Zikun, et al.
Publicado: (2023)

‘Beta-interferons’ and ‘oligoclonal bands’ in multiple sclerosis in India
por: Hassan, K. M.
Publicado: (2011)

Oral contraceptives combined with interferon β in multiple sclerosis
por: Pozzilli, Carlo, et al.
Publicado: (2015)

Identifying responders and nonresponders to interferon therapy in multiple sclerosis
por: Prosperini, Luca, et al.
Publicado: (2014)

Diminished heart beat non-stationarities in congestive heart failure
por: Camargo, Sabrina, et al.
Publicado: (2013)

Response to Interferon-Beta Treatment in Afro-Caribbeans with Multiple Sclerosis
por: Jeannin, S., et al.
Publicado: (2011)

Clinical testing for neutralizing antibodies to interferon-β in multiple sclerosis
por: Creeke, Paul I., et al.
Publicado: (2013)

Beta‐interferon exposure and onset of secondary progressive multiple sclerosis
por: Zhang, T., et al.
Publicado: (2015)

Peripheral Vasculitis, Intermediate Uveitis and Interferon Use in Multiple Sclerosis
por: Kinyas, Şeref, et al.
Publicado: (2016)

Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient
por: Malekzadeh, Masoud Mohammad, et al.
Publicado: (2020)

Defective gamma interferon production in leprosy. Reversal with antigen and interleukin 2
Publicado: (1983)

Autophagy diminishes the early interferon-β response to influenza A virus resulting in differential expression of interferon-stimulated genes
por: Perot, Brieuc P., et al.
Publicado: (2018)

Translation of IRF-1 Restricts Hepatic Interleukin-7 Production to Types I and II Interferons: Implications for Hepatic Immunity
por: Rueschenbaum, Sabrina, et al.
Publicado: (2021)

Amplification of poly(I:C)-induced interleukin-6 production in human bronchial epithelial cells by priming with interferon-γ
por: Okuma, Norikazu, et al.
Publicado: (2023)

Tetracyclines Diminish In Vitro IFN-γ and IL-17-Producing Adaptive and Innate Immune Cells in Multiple Sclerosis
por: Florou, Despoina T., et al.
Publicado: (2021)

Rotavirus susceptibility of antibiotic-treated mice ascribed to diminished expression of interleukin-22
por: Schnepf, Daniel, et al.
Publicado: (2021)

Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes
por: Perriard, Guillaume, et al.
Publicado: (2015)

Neurofibromatosis I and multiple sclerosis
por: Bergqvist, Christina, et al.
Publicado: (2020)

Influence of Interferon beta treatment on quality of life in multiple sclerosis patients
por: Simone, Isabella Laura, et al.
Publicado: (2006)

Beta-interferons in multiple sclerosis: A single center experience in India
por: Gupta, Salil, et al.
Publicado: (2010)

Early stage and long term treatment of multiple sclerosis with interferon-β
por: Applebee, Angela, et al.
Publicado: (2009)

Current Perspectives on Interferon Beta-1b for the Treatment of Multiple Sclerosis
por: Marziniak, Martin, et al.
Publicado: (2014)

Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta
por: Castrop, Florian, et al.
Publicado: (2013)

PEGylated interferon beta-1a in the treatment of multiple sclerosis – an update
por: Reuss, Reinhard
Publicado: (2013)

Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis
por: Cocco, Eleonora, et al.
Publicado: (2015)

Cutaneous Adverse Events Associated with Interferon-β Treatment of Multiple Sclerosis
por: Kolb-Mäurer, Annette, et al.
Publicado: (2015)

Neutralizing Antibodies Against Interferon-Beta in Korean Patients with Multiple Sclerosis
por: Hyun, Jae-Won, et al.
Publicado: (2018)

Thrombotic microangiopathy associated with interferon-beta treatment in patients with multiple sclerosis
por: Baghbanian, Seyed Mohammad, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kbcoqkmbfng1tmi944atuc8h80